Skip to main content
Clinical Trials/NCT06235866
NCT06235866
Enrolling By Invitation
Not Applicable

Risk Identification of Long-term Complications in the Recover Patients With Severe COVID-19

Wuhan Central Hospital1 site in 1 country500 target enrollmentFebruary 1, 2023
ConditionsSevere COVID-19

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Severe COVID-19
Sponsor
Wuhan Central Hospital
Enrollment
500
Locations
1
Primary Endpoint
Lung function
Status
Enrolling By Invitation
Last Updated
last year

Overview

Brief Summary

The investigators retrospectively analyze the clinical characteristics of severe COVID-19 in our hospital, and then establish a prediction model for long-term complications in patients with severe COVID-19, and strengthen follow-up to improve the prognosis of patients.

Detailed Description

At present, there is a lack of prediction models for the long-term complications of severe COVID-19. Therefore, the investigators used the hospital big data platform to retrospectively analyze the clinical characteristics of severe COVID-19 in our hospital, and conducted cohort follow-up of the changes in lung function including FEV1, FVC,FEV1% and DLCO, etc and and high-resolution CT of patients after discharge. COX model and other statistical methods were used to establish a prediction model for long-term complications of severe COVID-19, and early identification and intervention, strengthen follow-up, and improve the prognosis of patients.

Registry
clinicaltrials.gov
Start Date
February 1, 2023
End Date
November 1, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Wuhan Central Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The patient met the diagnostic criteria for severe COVID-19

Exclusion Criteria

  • Pregnant women Patients who died of COVID-19 Patients younger than 18 years of age without pulmonary CT

Outcomes

Primary Outcomes

Lung function

Time Frame: 1 year

Pulmonary function indicators improved gradually

Imaging of the lung

Time Frame: 1 year

The residual lesions in the lung were gradually absorbed

Study Sites (1)

Loading locations...

Similar Trials